亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

賴氨酸氯尼辛原料精品現貨

 
 
單價 10.00 / kg對比
銷量 暫無
發貨 湖北武漢市付款后48小時內
庫存 99000kg起訂1kg
品牌 福國藥業
含量 99%
包裝 25kg
過期 長期有效
更新 2021-09-12 12:54
 

湖北福國醫藥科技有限公司

企業會員第5年
資料未認證
保證金未繳納
詳細說明

賴氨酸氯尼辛

別名:氯尼辛賴氨酸;氯尼辛賴氨酸鹽;2-[(3-氯-2-甲基苯基)氨基]吡啶-3-羧酸 (2S)-2,6-二氨基己酸

英文名:Lysine clonixinate

英文別名:lysine clonixinate;l-lysine mono(2-((3-chloro-2-methylphenyl)amino)-3-pyridinecarboxylate);2-[(3-chloro-2-methyl-phenyl)amino]pyridine-3-carboxylic acid (2s)-2,6-diaminohexanoic acid;2-(2'-methyl-3'-chloroanilino)lysine nicotinate;L-Lysine clonixinate;Clonixic acid·L-lysine;levocloperastine fendizoate;levocloperastine phendizoate.

CAS:55837-30-4;42059-11-0

外觀:類白色結晶性粉末

用途:非甾體抗炎鎮痛藥;

包裝:5kg-25kg/桶;

CAS:55837-30-4

分子式:C19H25ClN4O4

分子量:408.88

熔點:208-214℃

儲存條件:2~8℃

舉報收藏 0評論 0
更多>本企業其它產品
甲潑尼龍琥珀酸鈉原料現貨供應 愈創藍油烴CAS#489-84-9廠家 烏芬那酯(氟滅酸丁酯)原料廠家 秋水仙堿現貨出廠 酒石酸托特羅定 甲氧普烯(S+ 烯蟲酯)現貨供應 制霉菌素原料現貨直銷
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |